06 October 2025
06 October 2025
Drug manufacturers who test and produce their generic medicines on US soil will now have access to priority review.
Rocket has pulled an approval application to the FDA, with the biotech considering offloading the asset via external partnerships.
Trogenix’s platform uses an AAV packed with two payloads in a “Trojan horse” approach to cancer treatment.
The combination is now the first and only approved dual maintenance therapy for ES-SCLC.
The approval is supported by data from the Phase IIb VISION-DMD trial.
Discovered at McMaster, the newly identified antibiotic presents a potential new therapy for individuals living with Crohn's disease.
The deal means Pfizer has committed to pricing current and any new medicines in all state Medicaid programs to the same prices in other developed countries.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
